These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 22243960)

  • 1. Structure-based design, synthesis and structure-activity relationships of dibenzosuberyl- and benzoate-substituted tropines as ligands for acetylcholine-binding protein.
    Edink E; Akdemir A; Jansen C; van Elk R; Zuiderveld O; de Kanter FJ; van Muijlwijk-Koezen JE; Smit AB; Leurs R; de Esch IJ
    Bioorg Med Chem Lett; 2012 Feb; 22(3):1448-54. PubMed ID: 22243960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple interaction regions in the orthosteric ligand binding domain of the α7 neuronal nicotinic acetylcholine receptor.
    Xiao Y; Hammond PS; Mazurov AA; Yohannes D
    J Chem Inf Model; 2012 Nov; 52(11):3064-73. PubMed ID: 23092444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetylcholine binding protein (AChBP) as template for hierarchical in silico screening procedures to identify structurally novel ligands for the nicotinic receptors.
    Akdemir A; Rucktooa P; Jongejan A; Elk Rv; Bertrand S; Sixma TK; Bertrand D; Smit AB; Leurs R; de Graaf C; de Esch IJ
    Bioorg Med Chem; 2011 Oct; 19(20):6107-19. PubMed ID: 21920761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 2.7 A structure of AChBP, homologue of the ligand-binding domain of the nicotinic acetylcholine receptor.
    Brejc K; van Dijk WJ; Smit AB; Sixma TK
    Novartis Found Symp; 2002; 245():22-9; discussion 29-32, 165-8. PubMed ID: 12027010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surface plasmon resonance biosensor based fragment screening using acetylcholine binding protein identifies ligand efficiency hot spots (LE hot spots) by deconstruction of nicotinic acetylcholine receptor α7 ligands.
    de Kloe GE; Retra K; Geitmann M; Källblad P; Nahar T; van Elk R; Smit AB; van Muijlwijk-Koezen JE; Leurs R; Irth H; Danielson UH; de Esch IJ
    J Med Chem; 2010 Oct; 53(19):7192-201. PubMed ID: 20828128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insight in nAChR subtype selectivity from AChBP crystal structures.
    Rucktooa P; Smit AB; Sixma TK
    Biochem Pharmacol; 2009 Oct; 78(7):777-87. PubMed ID: 19576182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico characterization of cytisinoids docked into an acetylcholine binding protein.
    Abin-Carriquiry JA; Zunini MP; Cassels BK; Wonnacott S; Dajas F
    Bioorg Med Chem Lett; 2010 Jun; 20(12):3683-7. PubMed ID: 20493692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docking to flexible nicotinic acetylcholine receptors: a validation study using the acetylcholine binding protein.
    Sander T; Bruun AT; Balle T
    J Mol Graph Model; 2010 Nov; 29(3):415-24. PubMed ID: 20884263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A computational study of the binding of 3-(arylidene) anabaseines to two major brain nicotinic acetylcholine receptors and to the acetylcholine binding protein.
    Slavov SH; Radzvilovits M; LeFrancois S; Stoyanova-Slavova IB; Soti F; Kem WR; Katritzky AR
    Eur J Med Chem; 2010 Jun; 45(6):2433-46. PubMed ID: 20236734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational evidence for the ligand selectivity to the alpha4beta2 and alpha3beta4 nicotinic acetylcholine receptors.
    Yuan H; Petukhov PA
    Bioorg Med Chem; 2006 Dec; 14(23):7936-42. PubMed ID: 16919961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of acetylcholine binding protein in the search for novel alpha7 nicotinic receptor ligands. In silico docking, pharmacological screening, and X-ray analysis.
    Ulens C; Akdemir A; Jongejan A; van Elk R; Bertrand S; Perrakis A; Leurs R; Smit AB; Sixma TK; Bertrand D; de Esch IJ
    J Med Chem; 2009 Apr; 52(8):2372-83. PubMed ID: 19331415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AChBP-targeted alpha-conotoxin correlates distinct binding orientations with nAChR subtype selectivity.
    Dutertre S; Ulens C; Büttner R; Fish A; van Elk R; Kendel Y; Hopping G; Alewood PF; Schroeder C; Nicke A; Smit AB; Sixma TK; Lewis RJ
    EMBO J; 2007 Aug; 26(16):3858-67. PubMed ID: 17660751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors.
    Brejc K; van Dijk WJ; Klaassen RV; Schuurmans M; van Der Oost J; Smit AB; Sixma TK
    Nature; 2001 May; 411(6835):269-76. PubMed ID: 11357122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polypeptide and peptide toxins, magnifying lenses for binding sites in nicotinic acetylcholine receptors.
    Tsetlin V; Utkin Y; Kasheverov I
    Biochem Pharmacol; 2009 Oct; 78(7):720-31. PubMed ID: 19501053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Octahydropyrrolo[3,4-c]pyrrole: a diamine scaffold for construction of either alpha4beta2 or alpha7-selective nicotinic acetylcholine receptor (nAChR) ligands. Substitutions that switch subtype selectivity.
    Bunnelle WH; Tietje KR; Frost JM; Peters D; Ji J; Li T; Scanio MJ; Shi L; Anderson DJ; Dyhring T; Grønlien JH; Ween H; Thorin-Hagene K; Meyer MD
    J Med Chem; 2009 Jul; 52(14):4126-41. PubMed ID: 19552432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel acetylcholine and carbamoylcholine analogues: development of a functionally selective alpha4beta2 nicotinic acetylcholine receptor agonist.
    Hansen CP; Jensen AA; Christensen JK; Balle T; Liljefors T; Frølund B
    J Med Chem; 2008 Dec; 51(23):7380-95. PubMed ID: 18989912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational studies of novel carbonyl-containing diazabicyclic ligands interacting with α4β2 nicotinic acetylcholine receptor (nAChR) reveal alternative binding modes.
    Kombo DC; Mazurov AA; Strachan JP; Bencherif M
    Bioorg Med Chem Lett; 2013 Sep; 23(18):5105-13. PubMed ID: 23937977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A model for short alpha-neurotoxin bound to nicotinic acetylcholine receptor from Torpedo californica: comparison with long-chain alpha-neurotoxins and alpha-conotoxins.
    Mordvintsev DY; Polyak YL; Levtsova OV; Tourleigh YV; Kasheverov IE; Shaitan KV; Utkin YN; Tsetlin VI
    Comput Biol Chem; 2005 Dec; 29(6):398-411. PubMed ID: 16290328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery, synthesis, biological evaluation and structure-based optimization of novel piperidine derivatives as acetylcholine-binding protein ligands.
    Shen J; Yang XC; Yu MC; Xiao L; Zhang XJ; Sun HJ; Chen H; Pan GX; Yan YR; Wang SC; Li W; Zhou L; Xie Q; Yu LQ; Wang YH; Shao LM
    Acta Pharmacol Sin; 2017 Jan; 38(1):146-155. PubMed ID: 27917874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and activity of substituted carbamates as potentiators of the alpha4beta2 nicotinic acetylcholine receptor.
    Springer SK; Woodin KS; Berry V; Boezio AA; Cao L; Clarkin K; Harmange JC; Hierl M; Knop J; Malmberg AB; McDermott JS; Nguyen HQ; Waldon D; Albrecht BK; McDonough SI
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5643-7. PubMed ID: 18805006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.